Search Results - EBARB, Theresa

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease: A Phase 2 Trial

    Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease: A Phase 2 Trial by JAIN, Nitin, REUBEN, James M, KANTARJIAN, Hagop, CHANGPING LI, HUI GAO, LEE, Bang-Ning, COHEN, Evan N, EBARB, Theresa, SCHEINBERG, David A, CORTES, Jorge

    Published in Cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure

    Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure by Cortes, Jorge, Quintás‐Cardama, Alfonso, Garcia‐Manero, Guillermo, O'Brien, Susan, Jones, Dan, Faderl, Stefan, Ebarb, Theresa, Giles, Francis, Thomas, Deborah, Kantarjian, Hagop

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease

    Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease by Jain, Nitin, Reuben, James M., Kantarjian, Hagop, Li, Changping, Gao, Hui, Lee, Bang‐Ning, Cohen, Evan N., Ebarb, Theresa, Scheinberg, David A., Cortes, Jorge

    Published in Cancer
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: